Published date : 11 June 2021
Management of stable ischaemic heart disease: an overview
Angina
Reviewed by
D. Beard
Published in
Int J Angiol 2021
Commentary
This article by Q. Radaideh et al. (Midwest Cardiovascular Research Foundation,USA) reviews the evidence on optimal medical therapy versus coronary revascularization in patients with stable ischaemic heart disease.
Percutaneous coronary intervention is currently recommended for patients with significant left main disease, large ischaemic myocardial burden, and patients with severe refractory angina despite maximal medical therapy.
Take-home message: The recently published ISCHEMIA trial has established the non-inferiority of medical therapy in comparison to coronary revascularisation in patients with moderate to severe ischaemia.